Dr. Cyril Varghese, MD

Dr. Varghese practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Varghese's NPI, 1194161802, was assigned on May 21, 2013. Dr. Varghese graduated from UT Southwestern Medical Center in 2013. Dr. Varghese holds Minnesota license 58253.

Dr. Varghese's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Varghese's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Varghese to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varghese practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Varghese's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Varghese is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Varghese's licenses on file in 2 states: Minnesota and Arizona.

Dmand AI lists chronic obstructive pulmonary disease (COPD), chronic respiratory failure and pulmonary fibrosis among the conditions Dr. Varghese treats.

CMS data shows 246 Medicare services from Dr. Varghese across 6 procedure codes in 2024, for 157 Medicare patients. Medicare paid $18,595 for them.

CMS counts 157 Medicare patients who saw Dr. Varghese in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Varghese's median patient age at 72, with 35% women.

In 2024, Dr. Varghese wrote 20 Medicare Part D claims. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $4,906 in total drug cost. In 2020, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Varghese for performance year 2024, reported as part of a group. Dr. Varghese accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Varghese, published from 2012 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Tomography, X-Ray Computed and Lung Neoplasms. Dr. Varghese has published most often in BMJ Case Rep. Dr. Varghese's most frequent co-authors are Tobias Peikert, MD, Brian J. Bartholmai, MD and Nicholas F. Larusso, MD.

CMS Open Payments shows 5 general payments to Dr. Varghese from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Ambu Inc. paid the most, $57.

Dr. Varghese graduated from UT Southwestern Medical Center in 2013.

Dr. Varghese is in network with 8 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.